What is the predominant isoform of lactate dehydrogenase (LDH) found in skeletal muscles?
Which enzyme is primarily responsible for the metabolism of alcohol?
What is the classification of urease?
Transferases are classified as which of the following?
Which of the following is a ribozyme?
Alpha-1 antitrypsin primarily inhibits which enzyme?
Which one of the following shows allosteric inhibition of glycolysis?
The predominant isozyme of LDH in lung is:
Citrate synthase is inhibited by -
Which of the following statements about the enzymes involved in the conversion of glucose to glucose-6-phosphate in glycolysis is true?
Explanation: ***LDH-5*** - **LDH-5**, also known as **M4 (four M subunits)**, is the predominant isoform found in **skeletal muscles** and the **liver**. - Its high concentration in skeletal muscle reflects its role in converting **pyruvate to lactate** under anaerobic conditions, which is essential for muscle activity when oxygen is limited. *LDH-1* - **LDH-1 (H4)** is predominantly found in the **heart** and **red blood cells**. - It is efficient at converting **lactate back to pyruvate**, which is crucial for aerobic metabolism in organs like the heart. *LDH-2* - **LDH-2 (H3M1)** is found in various tissues but is particularly abundant in the **reticuloendothelial system** and **white blood cells**. - It represents an intermediate isoform with a balance of properties between LDH-1 and LDH-5. *LDH-3* - **LDH-3 (H2M2)** is a more widely distributed isoform, predominantly found in the **lungs**, **lymphatic tissue**, and **kidneys**. - It also has intermediate catalytic properties, reflecting the metabolic diversity of these tissues.
Explanation: ***Alcohol dehydrogenase*** - **Alcohol dehydrogenase (ADH)** is the primary enzyme in the **cytosol** of hepatocytes responsible for the initial breakdown of ethanol to **acetaldehyde**. - This is the main pathway for alcohol metabolism, particularly at **low to moderate alcohol concentrations**, accounting for approximately **80-90%** of alcohol metabolism. *MEOS* - The **Microsomal Ethanol Oxidizing System (MEOS)**, primarily involving **CYP2E1**, becomes significant at **higher alcohol concentrations** or in chronic alcohol users. - While it contributes to alcohol metabolism, it is not the *primary* enzyme at typical consumption levels; ADH handles the bulk. *Catalase* - **Catalase** can metabolize alcohol, but its contribution is quantitatively **minor** compared to ADH and MEOS, accounting for less than **10%** of alcohol metabolism. - Catalase's primary role is to break down **hydrogen peroxide** into water and oxygen in peroxisomes. *Aldehyde dehydrogenase* - **Aldehyde dehydrogenase (ALDH)** is responsible for the **second step** of alcohol metabolism, converting acetaldehyde (produced by ADH) to acetate. - While crucial for alcohol metabolism, it acts on the **product** of ADH activity, not on ethanol itself, making ADH the primary enzyme for alcohol metabolism.
Explanation: ***Hydrolase*** - **Urease** catalyzes the hydrolysis of urea into **ammonia** and **carbon dioxide**. - **Hydrolases** are enzymes that catalyze the cleavage of a chemical bond by adding water. *Oxidoreductase* - **Oxidoreductases** catalyze **oxidation-reduction reactions** by transferring electrons. - Urease does not facilitate electron transfer; rather, it performs a **hydrolytic** breakdown. *Lyase* - **Lyases** catalyze the cleavage of various chemical bonds by means other than hydrolysis or oxidation, often forming a new double bond or ring structure. - Urease uses water to break a bond and does not form double bonds. *Ligase* - **Ligases** catalyze the **joining of two large molecules** by forming a new chemical bond, typically with ATP hydrolysis. - Urease breaks down a molecule, it does not join molecules.
Explanation: ***EC-2 (Transferases)*** - Transferases are enzymes that catalyze the **transfer of a functional group** (e.g., methyl, glycosyl, phosphate) from one molecule to another. - The Enzyme Commission (EC) number system classifies enzymes into **seven main classes**, with EC-2 specifically designating transferases. *EC-1 (Oxidoreductases)* - **Oxidoreductases** are enzymes that catalyze **oxidation-reduction reactions**, involving the transfer of electrons. - This class includes enzymes like **dehydrogenases** and **oxidases**, which are distinct from transferases as they do not transfer functional groups. *EC-3 (Hydrolases)* - **Hydrolases** are enzymes that catalyze the **hydrolysis of chemical bonds**, a process that involves the addition of water. - This group includes enzymes such as **esterases**, **peptidases**, and **glycosidases**, which break down molecules. *EC-4 (Lyases)* - **Lyases** are enzymes that catalyze the **breaking of various chemical bonds** by means other than hydrolysis or oxidation, often forming new double bonds or rings. - Examples include **decarboxylases** and **aldolases**, which remove groups without the involvement of water.
Explanation: ***Peptidyl Transferase*** - This enzyme, a component of the **large ribosomal subunit**, is responsible for forming **peptide bonds** between amino acids during protein synthesis. - It is unique because its catalytic activity is performed by **ribosomal RNA (rRNA)**, making it a ribozyme rather than a protein enzyme. *Ribonuclease* - Ribonucleases are a class of enzymes that **catalyze the degradation of RNA** into smaller components. - They are typically **protein-based enzymes** and do not exhibit catalytic activity stemming from RNA itself. *Transpeptidase* - Transpeptidases are protein enzymes primarily involved in **bacterial cell wall synthesis**, catalyzing the cross-linking of peptidoglycan chains. - They are the target of **beta-lactam antibiotics** like penicillin, which inhibit their protein-based enzymatic activity. *Poly A polymerase* - This enzyme adds a **polyadenosine (Poly A) tail** to the 3' end of messenger RNA (mRNA) precursors. - Poly A polymerase is a **protein enzyme** and its activity is not derived from an RNA molecule.
Explanation: ***Neutrophil elastase*** - **Alpha-1 antitrypsin (A1AT)** is a serpin that primarily inactivates **neutrophil elastase**, which is released by neutrophils during inflammation. - Deficiency in A1AT leads to unopposed **elastase activity** in the lungs, causing tissue destruction and conditions like **emphysema**. *Trypsin* - **Trypsin** is a serine protease produced in the pancreas that aids in protein digestion in the small intestine. - While A1AT can inhibit trypsin to some extent, its primary and most clinically significant target is **neutrophil elastase**. *Chymotrypsin* - **Chymotrypsin** is another **serine protease** involved in protein digestion, also produced by the pancreas. - It is not the primary target of **alpha-1 antitrypsin**; its inactivation is less crucial in the context of A1AT's protective role in the lungs. *Trypsinogen* - **Trypsinogen** is the inactive precursor (zymogen) of trypsin, which is activated in the duodenum. - A1AT would not primarily inhibit trypsinogen, as it acts on active proteases like **trypsin** and **elastase**.
Explanation: ***Citrate*** - **Citrate** is a classic **allosteric inhibitor** of **phosphofructokinase-1 (PFK-1)**, the key regulatory enzyme in glycolysis - It binds to an allosteric site (distinct from the active site), reducing PFK-1's affinity for **fructose-6-phosphate** - This is a **negative feedback mechanism** - when citrate accumulates (indicating sufficient ATP production via the citric acid cycle), glycolysis slows down *Malonic acid* - **Malonic acid** is a **competitive inhibitor** (NOT allosteric) of succinate dehydrogenase in the citric acid cycle - It structurally resembles succinate and competes for the active site directly *2,3-BPG* - **2,3-Bisphosphoglycerate (2,3-BPG)** is an **allosteric effector** of hemoglobin (decreases oxygen affinity), not an enzyme inhibitor in glycolysis - It binds to hemoglobin, not to glycolytic enzymes *Amino acid alanine* - **Alanine** is an allosteric inhibitor of **pyruvate kinase** (not a glycolytic regulator in this context) - While it does show allosteric inhibition, it acts on gluconeogenesis regulation in the liver, not as a direct glycolytic inhibitor
Explanation: ***LD-3*** - **LD-3** is the predominant **LDH isozyme** found in the **lungs**, spleen, pancreas, and lymph nodes. - Its elevation often suggests conditions affecting these organs, such as pulmonary embolism or pancreatitis. *LD-1* - **LD-1** is primarily associated with the **heart** and **red blood cells**. - Elevated levels are typically seen in conditions like myocardial infarction and hemolytic anemia. *LD-2* - **LD-2** is also found in the **heart** and **red blood cells**, though typically in lower concentrations than LD-1 in the heart. - It is often elevated after an MI, but typically LD-1 is elevated higher than LD-2 after an MI. *LD-5* - **LD-5** is predominantly found in the **liver** and **skeletal muscle**. - Its increase is indicative of liver damage or muscle injury, such as hepatitis or muscular dystrophy.
Explanation: ***ATP*** - **Citrate synthase**, a key enzyme in the Krebs cycle, is inhibited by **high levels of ATP**, indicating a high energy state in the cell. - This allosteric inhibition helps regulate the metabolic flux through the cycle, slowing it down when energy is abundant. *ADP* - **ADP** typically signifies a low energy state and would generally act as an **activator** rather than an inhibitor for metabolic pathways that produce ATP. - In this context, ADP would promote the activity of enzymes involved in energy generation, including those in the Krebs cycle. *Insulin* - **Insulin** is a hormone that promotes fuel storage and utilization, generally **activating** metabolic pathways rather than directly inhibiting enzymes like citrate synthase. - Its primary role is to regulate blood glucose levels and promote glucose uptake and utilization. *Glucagon* - **Glucagon** is a hormone that mobilizes fuel from storage and is typically associated with **catabolic processes**, often increasing metabolic activity in response to low blood glucose. - It does not directly inhibit citrate synthase; its main actions are on glucoregulation.
Explanation: ***Glucokinase is induced by insulin.*** - **Insulin** promotes glucose uptake and utilization in the liver and pancreatic beta cells, where glucokinase is primarily expressed. - Induction of **glucokinase** by insulin ensures that glucose is efficiently phosphorylated and trapped within hepatocytes when blood glucose levels are high. - This is a key mechanism for postprandial glucose homeostasis. *Incorrect: Hexokinase is specific for glucose.* - **Hexokinase** is NOT specific for glucose; it can phosphorylate various hexoses including **fructose**, **mannose**, and **galactose**. - Its broad substrate specificity distinguishes it from glucokinase, which has greater specificity for glucose. *Incorrect: Glucokinase is inhibited by glucose-6-phosphate.* - Unlike **hexokinase**, which is subject to product inhibition by glucose-6-phosphate, **glucokinase is NOT inhibited** by its product. - This lack of feedback inhibition allows glucokinase to continue phosphorylating glucose even when glucose-6-phosphate levels are elevated, which is appropriate for its role as a glucose sensor in liver and pancreatic beta cells. *Incorrect: Hexokinase has a high Km for glucose.* - **Hexokinase** has a **low Km** (~0.1 mM) for glucose, meaning it has high affinity and is saturated at normal blood glucose levels. - In contrast, **glucokinase** has a high Km (~10 mM), allowing it to respond proportionally to changes in blood glucose concentration.
Enzyme Classification and Nomenclature
Practice Questions
Enzyme Kinetics and Michaelis-Menten Equation
Practice Questions
Enzyme Inhibition: Competitive and Non-competitive
Practice Questions
Allosteric Regulation
Practice Questions
Coenzymes and Cofactors
Practice Questions
Isoenzymes and Clinical Significance
Practice Questions
Enzyme Regulation: Covalent Modification
Practice Questions
Enzyme Regulation: Zymogen Activation
Practice Questions
Enzyme Induction and Repression
Practice Questions
Ribozymes and Catalytic RNA
Practice Questions
Enzyme Diagnostic Applications
Practice Questions
Enzyme Therapy and Inhibitors as Drugs
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free